Title : CYP3A-status is associated with blood concentration and dose-requirement of tacrolimus in heart transplant recipients.

Pub. Date : 2021 Nov 1

PMID : 34725418






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CYP3A-status is associated with blood concentration and dose-requirement of tacrolimus in heart transplant recipients. Tacrolimus cytochrome P450 family 3 subfamily A member 4 Homo sapiens
2 High inter-individual variability in tacrolimus clearance is attributed to genetic polymorphisms of CYP3A enzymes. Tacrolimus cytochrome P450 family 3 subfamily A member 4 Homo sapiens
3 However, due to CYP3A phenoconversion induced by non-genetic factors, continuous changes in tacrolimus-metabolizing capacity entail frequent dose-refinement for optimal immunosuppression. Tacrolimus cytochrome P450 family 3 subfamily A member 4 Homo sapiens
4 In low CYP3A4 expressers carrying CYP3A5*3/*3, the dose-corrected tacrolimus level was significantly higher than in normal CYP3A4 expressers or in those with CYP3A5*1. Tacrolimus cytochrome P450 family 3 subfamily A member 4 Homo sapiens
5 Modification of the initial tacrolimus dose was required for all patients: dose reduction by 20% for low CYP3A4 expressers, a 40% increase for normal expressers and a 2.4-fold increase for CYP3A5*1 carriers. Tacrolimus cytochrome P450 family 3 subfamily A member 4 Homo sapiens
6 Although monitoring of tacrolimus blood concentration cannot be omitted, assaying recipients" CYP3A-status can guide optimization of the initial tacrolimus dose, and can facilitate personalized tacrolimus therapy during steroid withdrawal in the late post-operative period. Tacrolimus cytochrome P450 family 3 subfamily A member 4 Homo sapiens